Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 8;24(18):13846.
doi: 10.3390/ijms241813846.

Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers-Protein Interactions

Affiliations
Review

Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers-Protein Interactions

Carlos Gutierrez-Merino. Int J Mol Sci. .

Abstract

Amyloid β (Aβ) oligomers have been linked to Alzheimer's disease (AD) pathogenesis and are the main neurotoxic forms of Aβ. This review focuses on the following: (i) the Aβ(1-42):calmodulin interface as a model for the design of antagonist Aβ peptides and its limitations; (ii) proteolytic degradation as the major source of highly hydrophobic peptides in brain cells; and (iii) brain peptides that have been experimentally demonstrated to bind to Aβ monomers or oligomers, Aβ fibrils, or Aβ plaques. It is highlighted that the hydrophobic amino acid residues of the COOH-terminal segment of Aβ(1-42) play a key role in its interaction with intracellular protein partners linked to its neurotoxicity. The major source of highly hydrophobic endogenous peptides of 8-10 amino acids in neurons is the proteasome activity. Many canonical antigen peptides bound to the major histocompatibility complex class 1 are of this type. These highly hydrophobic peptides bind to Aβ and are likely to be efficient antagonists of the binding of Aβ monomers/oligomers concentrations in the nanomolar range with intracellular proteins. Also, their complexation with Aβ will protect them against endopeptidases, suggesting a putative chaperon-like physiological function for Aβ that has been overlooked until now. Remarkably, the hydrophobic amino acid residues of Aβ responsible for the binding of several neuropeptides partially overlap with those playing a key role in its interaction with intracellular protein partners that mediates its neurotoxicity. Therefore, these latter neuropeptides are also potential candidates to antagonize Aβ peptides binding to target proteins. In conclusion, the analysis performed in this review points out that hydrophobic endogenous brain neuropeptides could be valuable biomarkers to evaluate the risk of the onset of sporadic AD, as well as for the prognosis of AD.

Keywords: Alzheimer’s disease; amyloid β; calmodulin; canonical antigen peptides; endogenous hydrophobic peptides; neuropeptides; neurotoxicity; proteasome.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Scheme of Aβ oligomers (AβO) dynamics and neurotoxicity. AβOe and AβOi means AβO extracellular and intracellular, respectively. Generation of neurotoxic AβO are marked by red arrows. Black arrows are used for molecular mechanisms that attenuate the toxicity of AβO, stressing the protection that can be afforded by their complexation with endogenous antagonist Aβ peptides (AntPep).
Figure 2
Figure 2
Hydrophobicity plot of Aβ(1–42) segment 29–42 (blue) and of the designed peptide VFAFAMAFML (orange). The NH2-terminus amino acid residue of the peptide VFAFAMAFML has been aligned with the amino acid residue 31 of Aβ(1–42).

Similar articles

Cited by

References

    1. Tiraboschi P., Hansen L.A., Thal L.J., Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology. 2004;62:1984–1989. doi: 10.1212/01.WNL.0000129697.01779.0A. - DOI - PubMed
    1. Younkin S.G. The role of A beta 42 in Alzheimer’s disease. J. Physiol. Paris. 1998;92:289–292. doi: 10.1016/S0928-4257(98)80035-1. - DOI - PubMed
    1. Mucke L., Selkoe D.J. Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction. Cold Spring Harb. Perspect. Med. 2012;2:a006338. doi: 10.1101/cshperspect.a006338. - DOI - PMC - PubMed
    1. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally Secreted Oligomers of Amyloid β Protein Potently Inhibit Hippocampal Long-Term Potentiation in Vivo. Nature. 2002;416:535–539. doi: 10.1038/416535a. - DOI - PubMed
    1. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., Klein W.L. Alzheimer’s Disease-Affected Brain: Presence of Oligomeric Aβ Ligands (ADDLs) Suggests a Molecular Basis for Reversible Memory Loss. Proc. Natl. Acad. Sci. USA. 2003;100:10417–10422. doi: 10.1073/pnas.1834302100. - DOI - PMC - PubMed

LinkOut - more resources